Hostname: page-component-586b7cd67f-t7fkt Total loading time: 0 Render date: 2024-11-25T16:27:00.676Z Has data issue: false hasContentIssue false
  • English
  • Français

Family history of chronic disease and participation in healthy behaviours

Published online by Cambridge University Press:  24 August 2007

GODFREY A. GIBBISON  and
C. DOUGLAS JOHNSON
GODFREY A. GIBBISON*
Affiliation:
School of Economic Development, Georgia Southern University, USA
C. DOUGLAS JOHNSON
Affiliation:
College of Business, Georgia Gwinnett College, USA
*
*Correspondence to: Godfrey A. Gibbison. School of Economic Development, Georgia Southern University, P.O. Box 8152, Statesboro, GA 30460, USA. Email: [email protected]
Get access Rights & Permissions [Opens in a new window]

Abstract:

This article presents an investigation into whether individuals incorporate information on their family genetic (health) endowment into decision making regarding participation in behaviours related to the production of health capital. Competing theoretical perspectives exist as to how genetic endowment should affect participation in health-related behaviours. There is also a growing consensus that the availability of genetic information holds important consequences for the individual in terms of investment in human capital, the pricing and availability of health insurance, and labour market opportunity. Therefore, the question of how individuals use the greater availability of genetic data is important. Our empirical results indicate that poor genetic endowment tends to be associated with a lower probability of participation in cigarette smoking, but also a lower probability of participation in regular exercise.

Type
Articles
Information
Health Economics, Policy and Law , Volume 2 , Issue 3 , July 2007 , pp. 297 - 315
Copyright
Cambridge University Press

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Armstrong, K., Weber, B., FitzGerald, G., Hershey, J.C., Pauly, M.V., Lemaire, J., Subramaian, K., and Asch, D.A. (2003),‘Life insurance and breast cancer risk assessment: adverse selection, genetic testing decisions, and discrimination’, American Journal of Medical Genetics, 120A: 359–364.CrossRefGoogle ScholarPubMed
Barrow, C. (1998). Family in the Caribbean: Themes and Perspectives, Kingston: Ian Randle Publishers.Google Scholar
Becker, G.S. (1965), ‘A theory of the allocation of time’, Economic Journal,75:493–517.CrossRefGoogle Scholar
Birch, S. and Stoddart, G. (1991), ‘Incentives to be healthy: an economic model of health-related behaviour’, in Lopez-Casasnovas, G(ed.), Incentives in Health Services, Barcelona: Springer-Verlag.Google Scholar
BrownH.S., III H.S., III, Pagan, J.A., and Bastida, E. (2005), ‘The impact of diabetes on employment: genetic IVs in a bivariate probit’, Health Economics, 14:537–544.CrossRefGoogle Scholar
Chen, S., Shogren, J.F., Orazem, P.F., and Crocker, T. D. (2002), ‘Prices and health: identifying the effects of nutrition, exercise, and medication choices on blood pressure’, American Journal of Agricultural Economics, 84: 990–1002.CrossRefGoogle Scholar
Chiappetta, T.O. (2005), ‘Managing healthcare costs’, Public Personnel Management,34:313–320.CrossRefGoogle Scholar
Chodick, G., Heymann, A.D., Wood, F., and Kokia, E. (2005), ‘The direct medical cost of diabetics in Israel’, European Journal of Health Economics, 6: 166–171.CrossRefGoogle ScholarPubMed
Clarke, E. (1999) (1957), My Mother who Fathered Me, Kingston: The Press University of the West Indies.Google Scholar
Coulter, C.H. (2006), ‘The employer’s case for health management’, Benefits Quarterly, 22: 23–33.Google ScholarPubMed
Dickie, M. and Gerking, S. (1997), ‘Genetic risk factors and offsetting behaviour: the case of skin cancer’, Journal of Risk Uncertainty, 15: 81–97.CrossRefGoogle Scholar
Dow, W.H., Holmes, J., Philipson, T., and Sala-i-Martin, X. (1999), ‘Longevity complementarities under competing risks’, American Economic Review, 89(5):1358–1371.CrossRefGoogle Scholar
Ganz, M.L.(2001), ‘Family health effects: complements or substitutes’, Health Economics,10:699–714.CrossRefGoogle ScholarPubMed
Gorin, S.S. (2005), ‘Correlates of colorectal cancer screening compliance among urban Hispanics’, Journal of Behavioural Medicine, 28(2):125–137.CrossRefGoogle ScholarPubMed
Greene, W.A. (2000), Econometric Analysis, 4th edition, New Jersey: Prentice Hall.Google Scholar
Grossman, M. (1972), ‘On the concept of health capital and the demand for health’, Journal of Political Economy, 80(2): 223–255.CrossRefGoogle Scholar
Hedgecoe, A. (1996), ‘Genetic catch-22: Testing, risk and private health insurance’, Business and Professional Ethics Journal, 15(2):69–85.CrossRefGoogle ScholarPubMed
Hedgecoe, A. (2004), The Politics of Personalized Medicine: Pharmacogenetics in the Clinic, Cambridge: Cambridge University PressCrossRefGoogle Scholar
Kenkel, D. S. (1991), ‘Health behavior, health knowledge and schooling’, The Journal of Political Economy, 99(2): 287–305.CrossRefGoogle Scholar
Lee, M. and Kobayashi, S. (2001), ‘Proportional treatment effects for count response panel data: effects of binary exercise on health care demand’, Health Economics, 10:411–428.CrossRefGoogle ScholarPubMed
Lee, J.M., Turini, M., Botteman, M.F., Stpehens, J.M., and Pashos, C.L. (2004), ‘Economic burden of head and neck cancer: a literature review’, European Journal of Health Economics, 5: 70–80.CrossRefGoogle ScholarPubMed
Leigh, J.P. and Dhir, R. (1997), ‘Schooling and frailty among seniors’, Economics of Education Review, 16(1): 45–57.CrossRefGoogle Scholar
Lemaire, J., Subramanian, K., Armstrong, K., and Asch, D.A. (2000), ‘Pricing term insurance in the presence of a family history of breast or ovarian cancer’, North American Actuarial Journal, 4(2): 75–87.CrossRefGoogle Scholar
Liang, W., Yuan, E., Mandelblatt, J.S., and Pasick, R. (2004), ‘How do older Chinese women view health and cancer screening? Results from focus groups and implications for intervention’, Ethnicity and Health, 9(3): 283–304.CrossRefGoogle Scholar
Lu, L., Macdonald, A., and Wekwete, C. (2006), ‘Premium rates based on genetic studies: how reliable are they?’, Working Paper No. 06/3 (www.ma.hw.ac.uk/ams/girc/publications.php).Google Scholar
Macdonald, A. (2003), ‘Genetics and insurance: what have we learned so far?’, Scandinavian Actuarial Journal, 4: 324–348.CrossRefGoogle Scholar
Macdonald, A., Waters, H.R., and Wekwete, C.T. (2005), ‘A model for coronary heart disease and stroke with applications to critical illness insurance underwriting I: the model’, North American Actuarial Journal, 9(1): 13–40.CrossRefGoogle Scholar
Manning, W.G., Keller, E.B., Newhouse, J.P., Sloss, E.M., and Wasserman, J. (1991), The Costs of Poor Health Habits, Cambridge, MA: Harvard University Press.CrossRefGoogle Scholar
Nabkasorn, C., Miyai, N., Sootmongkol, N., Junprasert, S., Yamamoto, H., Arita, M., and Miyashita, K. (2005), ‘Effects of physical exercise on depression, neuroendocrine stress hormones, and physiological fitness in adolescent females with depressive symptoms’, European Journal of Public Health, 16: 179–184.CrossRefGoogle ScholarPubMed
Nicholl, J.P., Coleman, P., and Brazier, J.E. (1994), ‘Health and healthcare costs and benefits of exercise’, PharmacoEconomics, 5(2): 109–122.CrossRefGoogle ScholarPubMed
Ogloblin, C. and Brock, G. (2003), ‘Smoking in Russia: the “Marlboro Man” rides but without “Virginia Slims” for now’, Comparative Economic Studies, 45:87–103.CrossRefGoogle Scholar
Ory, C., Vanderplas, A., Dezii, C., and Chang, E. (2005), ‘Congestive heart failure: attributable costs within the managed care setting’, Journal of Pharmaceutical Finance, Economics and Policy, 14(2): 87–97.CrossRefGoogle Scholar
Osann, K.E. (1991), ‘Lung cancer in women: the importance of smoking, family history of cancer, and medical history of respiratory disease’, Cancer Research, 51:4893–4897.Google ScholarPubMed
Parrott, R., Silk, K., Weiner, J., Condit, C., Harris, T., and Bernhardt, J. (2004), ‘Deriving lay models of uncertainty about genes’ role in illness causation to guide communication about human genetics’, Journal of Communication, 54(1) 105–122.CrossRefGoogle Scholar
Payne, K.A., Kuybrechts, K. F., Craig Green, T. J., and Klittich, W.S. (2002), ‘Long-term cost-of-illness in stroke: an international review’, PharmacoEconomics, 20:813–825.CrossRefGoogle ScholarPubMed
Schwartz, A.G., Yang, P., and Swanson, G.M. (1996), ‘Familial risk of lung cancer among nonsmokers and their relatives’, American Journal of Epidemiology, 144(6): 554–562.CrossRefGoogle ScholarPubMed
Sharf, B.F., Stelljes, L.A., and Gordon, H.S. (2005), ‘A little bitty spot and I’m a big man: Patients’ perspectives on refusing diagnosis of treatment for lung cancer’, Psycho-oncology, 14: 636–646.CrossRefGoogle Scholar
Tabarrok, A. (1994), ‘Genetic testing: an economic and contractarian analysis’, Journal of Health Economics, 13: 75–91.CrossRefGoogle ScholarPubMed
Thorpe, K.E. (2005), ‘The rise in health care spending and what to do about it?’, Health Affairs, 24: 1436–1445.CrossRefGoogle Scholar